This page shows the latest Strattera news and features for those working in and with pharma, biotech and healthcare.
Strattera (atomoxetine) and erectile dysfunction therapy Cialis (tadalafil).
It is also the first alternative to Eli Lilly's non-stimulant ADHD therapy Strattera (atomoxetine) in Europe, providing another option for the approximately 10% of people with the condition who
to $588m and attention-deficit hyperactivity disorder (ADHD) drug Strattera (atomoxetine) brought in $201m, up 23 per cent.
month - along with Roche's Lucentis (ranibizumab) for pathologic myopia and Eli Lilly's attention deficit hyperactivity disorder (ADHD) therapy Strattera (atomoxetine).
Adults in the UK with attention deficit hyperactivity disorder (ADHD) who were not prescribed medicine as a child will now have access to Lilly's Strattera after it was approved by ... Strattera's new licence is backed by results from clinical trials
The US court of appeals has upheld the validity of Eli Lilly &Company's patent for ADHD drug Strattera. ... However, the most recent decision upholds Lilly's method-of-use patent which provides protection for Strattera until May, 2017.
More from news
Approximately 1 fully matching, plus 15 partially matching documents found.
These classes were methylphenidate-based products like Johnson &Johnson's Concerta (methylphenidate hydrochloride) and Lilly's non-stimulant Strattera (atomoxetine).
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...